Single User License
INR 11965
Site License
INR 23930
Corporate User License
INR 35894

Service Tax Additional

select a format
Price

Single User License
USD 175
Site License
USD 350
Corporate User License
USD 525

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Omega Pharma NV-Strategy, SWOT and Corporate Finance Report

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report


  Request for Sample Report

Executive Summary

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Omega Pharma NV required for business and competitor intelligence needs

A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis

An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments

Intelligence on Omega Pharma NV's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Omega Pharma NV, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Omega Pharma NV and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Omega Pharma NV as a prospective partner, vendor or supplier

Support sales activities by understanding your customers' businesses better

Stay up to date on Omega Pharma NV's business structure, strategy and prospects

Key Highlights

Omega Pharma (Omega or 'the company'), a company owned by Omega Pharma Invest NV, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. It is headquartered in Nazareth, Belgium, and employs about 2,500 people.

Company Snapshot

Omega Pharma NV: Company Overview

Omega Pharma NV: Overview and Key Facts

Omega Pharma NV: Overview

Omega Pharma NV: Key Facts

Omega Pharma NV: Key Employees

Omega Pharma NV: Key Employee Biographies

Omega Pharma NV: Major Products and Services

Omega Pharma NV: Company History

Omega Pharma NV: Management Statement

Omega Pharma NV: Key Competitors

Omega Pharma NV: Company Analysis

Omega Pharma NV: Business Description

Omega Pharma NV: SWOT Analysis

Omega Pharma NV: SWOT Overview

Omega Pharma NV: Strengths

Omega Pharma NV: Weaknesses

Omega Pharma NV: Opportunities

Omega Pharma NV: Threats

Omega Pharma NV: Corporate Financial Deals Activity

Omega Pharma NV: Financial Deals Overview

Omega Pharma NV: Targets and Partners

Omega Pharma NV: Top Deals 2012-2016YTD*

Omega Pharma NV: Advisors

Omega Pharma NV: Top Legal Advisors

Omega Pharma NV: Mergers and Acquisitions

Omega Pharma NV: Partnership

Omega Pharma NV: Private Equity and Ownership

Omega Pharma NV: Recent Developments

Omega Pharma NV: News and Events Summary

Omega Pharma NV: Contracts

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Omega Pharma NV: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Figure 2: Omega Pharma NV: M&A Average Deal Size-Value (US$m)

Figure 3: Omega Pharma NV: M&A Volume and Value Trend (2012-YTD*2016)

Figure 4: Omega Pharma NV: M&A Activity by Geography (2012-YTD*2016)

Figure 5: Omega Pharma NV: Partnership Volume and Value Trend (2012-YTD*2016)

Figure 6: Omega Pharma NV: Partnership Trend by Deal Type (2012-YTD*2016)

Figure 7: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2012-YTD*2016)

Figure 8: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2012-YTD*2016)

Table 1: Omega Pharma NV: Key Facts

Table 2: Omega Pharma NV: Key Employees

Table 3: Omega Pharma NV: Key Competitors

Table 4: Omega Pharma NV: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Table 5: Omega Pharma NV: M&A Average Deal Size-Value (US$m)

Table 6: Omega Pharma NV: Targets and Partners

Table 7: Omega Pharma NV: Top Deals 2012-2016YTD*

Table 8: Omega Pharma NV: Legal Advisor Ranking by Value (US$m)

Table 9: Omega Pharma NV: M&A Volume and Value Trend (2012-YTD*2016)

Table 10: Omega Pharma NV: M&A Activity by Geography (2012-YTD*2016)

Table 11: Omega Pharma NV: Partnership Volume and Value Trend (2012-YTD*2016)

Table 12: Omega Pharma NV: Partnership Trend by Deal Type (2012-YTD*2016)

Table 13: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2012-YTD*2016)

Table 14: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2012-YTD*2016)

Table 15: Omega Pharma NV: News and Events Summary

Table 16: Omega Pharma NV: Contracts

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Omega Pharma NV


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com